Re: 'Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe' by Lange et al, Inna, Friesen, Saluzzo Francesca, Aubry Alexandra, Alexander Indra, Mathys Vanessa, Atanasovav Yuliana, Obrovac Mihaela, ?mak Ljiljiana, Despo Pieridou, Dvo?ákov V?ra, et al. , Clinical Microbiology and Infection, Jan-09-2024, Volume 30, Issue 9, (2024)